Study ProtocolPublished 7 October 2026Comparative efficacy of naltrexone-accelerated versus sublingual buprenorphine in opioid withdrawal management and initiating injectable naltrexone treatment: study protocol for a randomized controlled trialSaeede Jafari · Afarin Rahimi-Movaghar · Alireza Noroozi · Pooneh Malekifar · Akbar FotouhiFrontiers in Psychiatrydoi 10.3389/fpsyt.2026.1933443
Original ResearchPublished 10 September 2026Deciphering the impact of genetic variants on vulnerability to Opioid Use DisorderRajashree Chakraborty · Chittibabu Guda · Avinash VeerappaFrontiers in Cellular Neurosciencedoi 10.3389/fncel.2026.1814602
Original ResearchPublished 28 August 2026Genetic modulation of oxycodone self-administration trajectories: from initiation to escalating burst patternsCaleb I. Hodges · Eamonn P. Duffy · Jonathan O. Ward · Luanne H. Hale · Cove C. Andrews · Laura M. Saba · Marissa A. Ehringer · Ryan K. BachtellFrontiers in Behavioral Neurosciencedoi 10.3389/fnbeh.2026.1913370
Brief Research ReportPublished 2 June 2026Targeting recovery capital for adolescents through treatment for opioid use disorder: a pilot expansion of the Youth Opioid Recovery Support interventionLexi Taylor · Kevin Wenzel · Kamala Mallik-Kane · Christopher Pfeltz · Elise Massie · Katherine Davis · Luciana Lavorato · Marc FishmanFrontiers in Adolescent Medicinedoi 10.3389/fradm.2026.1720332
